Details of the Drug
General Information of Drug (ID: DMND2AS)
Drug Name |
Diisopropylphosphono Group
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
Diisopropyl phosphonate; Phosphonic acid, bis(1-methylethyl) ester; Diisopropylphosphine oxide; Phosphonic acid, diisopropyl ester; O,O-Diisopropyl phosphonate; Isopropyl phosphonate; Diisopropyl hydrogen phosphonate; Isopropyl phosphonate ((C3H7O)2HPO); Diisopropylphosphonate; DIISOPROPYLPHOSPHONO GROUP; NSC 82344; O,O-Diisopropyl phosphite; bis(propan-2-yl) phosphonate; BLKXLEPPVDUHBY-UHFFFAOYSA-N; EINECS 217-317-7; BRN 1703675; diisopropylphosponate; di-i-Propylphosphite; AC1O3FKK; diisopropoxy(oxo)phosphonium
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 165.15 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 1.6 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 4 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 0 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 3 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||